LivaNova PLC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
LivaNova PLC (LIVN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$10.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$10.98M, a 121.61% decline year-over-year.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$10.73M, a 128.66% decline year-over-year.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $1.82M.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$2.60M, a 109.97% decline year-over-year.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $87.50M.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$52.29M, a 358.39% decline from fiscal 2023.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $20.24M.
- LivaNova PLC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$40.94M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 2 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 7 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 8 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.98M 10-Q · filed 2026-08-05 | -$21.72M 10-Q · filed 2026-08-05 | -$19.89M derived: sum of 3 quarters · filed 2026-08-05 | -$22.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$10.73M 10-Q · filed 2026-05-06 | -$8.91M derived: sum of 2 quarters · filed 2026-05-06 | -$11.51M derived: sum of 3 quarters · filed 2026-05-06 | $39.33M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$783.00K derived: sum of 2 quarters · filed 2026-02-25 | $50.06M derived: sum of 3 quarters · filed 2026-08-05 | $87.50M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$2.60M 10-Q · filed 2025-11-05 | $48.24M derived: sum of 2 quarters · filed 2026-08-05 | $85.68M 10-Q · filed 2025-11-05 | $32.21M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $50.84M 10-Q · filed 2026-08-05 | $88.28M 10-Q · filed 2026-08-05 | $34.82M derived: sum of 3 quarters · filed 2026-08-05 | $60.93M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $37.44M 10-Q · filed 2026-05-06 | -$16.02M derived: sum of 2 quarters · filed 2026-05-06 | $10.09M derived: sum of 3 quarters · filed 2026-05-06 | $2.48M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$53.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$27.35M derived: sum of 2 quarters · filed 2026-02-25 | -$34.96M derived: sum of 3 quarters · filed 2026-02-25 | -$52.29M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $26.12M 10-Q · filed 2025-11-05 | $18.50M derived: sum of 2 quarters · filed 2025-11-05 | $1.18M 10-Q · filed 2025-11-05 | $28.10M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$7.61M 10-Q · filed 2025-08-06 | -$24.94M 10-Q · filed 2025-08-06 | $1.98M derived: sum of 3 quarters · filed 2026-02-25 | -$17.24M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$17.32M 10-Q · filed 2025-05-07 | $9.60M derived: sum of 2 quarters · filed 2026-02-25 | -$9.63M derived: sum of 3 quarters · filed 2026-02-25 | -$4.17M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $26.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.70M derived: sum of 2 quarters · filed 2026-02-25 | $13.15M derived: sum of 3 quarters · filed 2026-02-25 | $20.24M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$19.22M 10-Q · filed 2024-10-31 | -$13.77M derived: sum of 2 quarters · filed 2024-10-31 | -$6.68M 10-Q · filed 2024-10-31 | $38.30M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $5.45M 10-Q · filed 2024-08-01 | $12.54M 10-Q · filed 2024-08-01 | $57.52M derived: sum of 3 quarters · filed 2025-02-25 | $19.29M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $7.09M 10-Q · filed 2024-05-03 | $52.07M derived: sum of 2 quarters · filed 2025-02-25 | $13.84M derived: sum of 3 quarters · filed 2025-02-25 | -$24.90M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $44.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $6.75M derived: sum of 2 quarters · filed 2025-02-25 | -$31.99M derived: sum of 3 quarters · filed 2025-02-25 | -$40.94M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$38.23M 10-Q · filed 2023-11-01 | -$76.97M derived: sum of 2 quarters · filed 2023-11-01 | -$85.93M 10-Q · filed 2023-11-01 | -$96.28M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$38.74M 10-Q · filed 2023-07-26 | -$47.69M 10-Q · filed 2023-07-26 | -$58.05M derived: sum of 3 quarters · filed 2024-02-29 | -$77.94M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$8.96M 10-Q · filed 2023-05-03 | -$19.31M derived: sum of 2 quarters · filed 2024-02-29 | -$39.21M derived: sum of 3 quarters · filed 2024-02-29 | -$18.07M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$30.25M derived: sum of 2 quarters · filed 2024-02-29 | -$9.12M derived: sum of 3 quarters · filed 2024-02-29 | -$34.99M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | -$19.90M 10-Q · filed 2022-11-02 | $1.24M derived: sum of 2 quarters · filed 2022-11-02 | -$24.63M 10-Q · filed 2022-11-02 | $13.56M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $21.14M 10-Q · filed 2022-08-03 | -$4.73M 10-Q · filed 2022-08-03 | $33.46M derived: sum of 3 quarters · filed 2023-02-27 | $58.16M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$25.87M 10-Q · filed 2022-05-04 | $12.32M derived: sum of 2 quarters · filed 2023-02-27 | $37.03M derived: sum of 3 quarters · filed 2023-02-27 | $54.46M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $38.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $62.90M derived: sum of 2 quarters · filed 2023-02-27 | $80.33M derived: sum of 3 quarters · filed 2023-02-27 | $47.20M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $24.70M 10-Q · filed 2021-11-03 | $42.14M derived: sum of 2 quarters · filed 2021-11-03 | $9.01M 10-Q · filed 2021-11-03 | $31.23M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $17.43M 10-Q · filed 2021-07-28 | -$15.70M 10-Q · filed 2021-07-28 | $6.52M derived: sum of 3 quarters · filed 2022-03-01 | -$21.91M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$33.13M 10-Q · filed 2021-04-28 | -$10.91M derived: sum of 2 quarters · filed 2022-03-01 | -$39.35M derived: sum of 3 quarters · filed 2022-03-01 | -$23.81M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $22.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$6.22M derived: sum of 2 quarters · filed 2022-03-01 | $9.32M derived: sum of 3 quarters · filed 2022-03-01 | $5.08M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$28.44M 10-Q · filed 2020-10-29 | -$12.90M derived: sum of 2 quarters · filed 2020-10-29 | -$17.13M 10-Q · filed 2020-10-29 | -$41.37M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $15.54M 10-Q · filed 2020-07-29 | $11.30M 10-Q · filed 2020-07-29 | -$12.93M derived: sum of 3 quarters · filed 2021-03-01 | -$10.54M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$4.24M 10-Q · filed 2020-04-30 | -$28.47M derived: sum of 2 quarters · filed 2021-03-01 | -$26.08M derived: sum of 3 quarters · filed 2021-03-01 | -$83.63M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$21.84M derived: sum of 2 quarters · filed 2021-03-01 | -$79.39M derived: sum of 3 quarters · filed 2021-03-01 | -$69.79M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $2.39M 10-Q · filed 2019-10-30 | -$55.16M derived: sum of 2 quarters · filed 2019-10-30 | -$45.56M 10-Q · filed 2019-10-30 | -$38.72M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$57.55M 10-Q · filed 2019-07-31 | -$47.95M 10-Q · filed 2019-07-31 | -$41.10M derived: sum of 3 quarters · filed 2020-03-02 | -$3.50M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $9.60M 10-Q · filed 2019-05-01 | $16.44M derived: sum of 2 quarters · filed 2020-03-02 | $54.04M derived: sum of 3 quarters · filed 2020-03-02 | $109.88M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $44.44M derived: sum of 2 quarters · filed 2020-03-02 | $100.28M derived: sum of 3 quarters · filed 2020-03-02 | $113.80M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $37.60M 10-Q · filed 2018-11-01 | $93.44M derived: sum of 2 quarters · filed 2018-11-01 | $106.96M 10-Q · filed 2018-11-01 | $63.81M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $55.84M 10-Q · filed 2018-08-02 | $69.36M 10-Q · filed 2018-08-02 | $26.21M derived: sum of 3 quarters · filed 2019-03-18 | $25.77M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $13.52M 10-Q · filed 2018-05-03 | -$29.63M derived: sum of 2 quarters · filed 2019-03-18 | -$30.06M derived: sum of 3 quarters · filed 2019-03-18 | -$45.86M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$43.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$43.58M derived: sum of 2 quarters · filed 2019-03-18 | -$59.38M derived: sum of 3 quarters · filed 2019-03-18 | -$14.26M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | -$436.00K 10-Q · filed 2017-11-02 | -$16.23M derived: sum of 2 quarters · filed 2017-11-02 | $28.89M 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | -$15.80M 10-Q · filed 2017-08-09 | $29.32M 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | $45.12M 10-Q · filed 2017-05-03 | |||||||
| 2015-12-31 | -$50.83M 10-K · filed 2017-03-01 | -$50.83M 10-K · filed 2018-02-28 | ||||||
| 2015-10-18 | $569.00K 10-Q · filed 2016-11-02 | $569.08K 10-Q · filed 2015-12-02 | $733.14K 10-Q · filed 2015-12-08 | $256.00K 10-Q · filed 2016-11-02 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | ||||||
| 2015-07-24 | $164.00K 10-Q · filed 2016-08-05 | -$313.00K 10-Q · filed 2016-08-05 | ||||||
| 2015-04-24 | -$477.00K 10-Q · filed 2016-05-09 | -$3.86M 10-K · filed 2018-02-28 | ||||||
| 2014-10-24 | -$1.11M 10-Q · filed 2015-12-08 | -$1.20M 10-Q · filed 2015-12-08 | ||||||
| 2014-04-25 | $287.00K 10-K · filed 2017-03-01 | |||||||
| 2013-04-26 | -$254.00K 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |